Erik Schrumpf
- Professor emeritus; MD, PhD
Publications 2020
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
Clin Exp Immunol, 203 (2), 304-314
DOI 10.1111/cei.13541, PubMed 33089489
Publications 2018
Natural killer T cells mediate inflammation in the bile ducts
Mucosal Immunol, 11 (6), 1582-1590
DOI 10.1038/s41385-018-0066-8, PubMed 30115993
Publications 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
Gut, 67 (8), 1517-1524
DOI 10.1136/gutjnl-2016-313598, PubMed 28779025
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
J Hepatol, 67 (3), 549-558
DOI 10.1016/j.jhep.2017.05.009, PubMed 28529147
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
J Hepatol, 66 (6), 1214-1222
DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Gastroenterology, 152 (8), 1975-1984.e8
DOI 10.1053/j.gastro.2017.02.038, PubMed 28274849
Publications 2016
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
Liver Int, 37 (3), 458-465
DOI 10.1111/liv.13238, PubMed 27558072
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Gut, 66 (4), 611-619
DOI 10.1136/gutjnl-2015-310500, PubMed 26887816
Publications 2015
Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
Transplant Direct, 1 (9), e39
DOI 10.1097/TXD.0000000000000548, PubMed 27500239
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
Hepatology, 61 (5), 1651-9
DOI 10.1002/hep.27707, PubMed 25644509
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013
Scand J Gastroenterol, 50 (6), 797-808
DOI 10.3109/00365521.2015.1036359, PubMed 25959101
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process
Hepatology, 63 (4), 1357-67
DOI 10.1002/hep.28256, PubMed 26418478
Primary sclerosing cholangitis - the Norwegian experience
Scand J Gastroenterol, 50 (6), 781-96
DOI 10.3109/00365521.2015.1028996, PubMed 25866138
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Hepatology, 62 (1), 188-97
DOI 10.1002/hep.27825, PubMed 25833813
Publications 2014
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease
Liver Int, 34 (10), 1488-95
DOI 10.1111/liv.12492, PubMed 24517468
Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population
PLoS One, 9 (12), e114486
DOI 10.1371/journal.pone.0114486, PubMed 25521205
Publications 2013
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4
Hepatology, 58 (3), 1074-83
DOI 10.1002/hep.25977, PubMed 22821403
Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease
Clin Gastroenterol Hepatol, 11 (5), 517-23
DOI 10.1016/j.cgh.2012.12.027, PubMed 23333218
Liver abnormalities in bowel diseases
Best Pract Res Clin Gastroenterol, 27 (4), 531-42
DOI 10.1016/j.bpg.2013.06.013, PubMed 24090940
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Nat Genet, 45 (6), 670-5
DOI 10.1038/ng.2616, PubMed 23603763
Publications 2012
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Epigenetics, 7 (11), 1249-57
DOI 10.4161/epi.22191, PubMed 22983262
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
J Hepatol, 57 (2), 366-75
DOI 10.1016/j.jhep.2012.03.031, PubMed 22521342
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study
Scand J Gastroenterol, 47 (8-9), 1021-9
DOI 10.3109/00365521.2012.685754, PubMed 22577871
Publications 2011
TGR5 sequence variation in primary sclerosing cholangitis
Dig Dis, 29 (1), 78-84
DOI 10.1159/000324138, PubMed 21691110
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis
Hepatology, 53 (6), 1967-76
DOI 10.1002/hep.24299, PubMed 21413052
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9
Hepatology, 53 (6), 1977-85
DOI 10.1002/hep.24307, PubMed 21425313
Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients
Inflamm Bowel Dis, 18 (3), 536-45
DOI 10.1002/ibd.21699, PubMed 21456044
Publications 2010
Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue
J Hepatol, 54 (2), 374-85
DOI 10.1016/j.jhep.2010.09.002, PubMed 21067838
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis
PLoS One, 5 (8), e12403
DOI 10.1371/journal.pone.0012403, PubMed 20811628
Update on primary sclerosing cholangitis
Dig Liver Dis, 42 (6), 390-400
DOI 10.1016/j.dld.2010.01.011, PubMed 20172772
Primary sclerosing cholangitis
Best Pract Res Clin Gastroenterol, 24 (5), 655-66
DOI 10.1016/j.bpg.2010.07.005, PubMed 20955968
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
Nat Genet, 43 (1), 17-9
DOI 10.1038/ng.728, PubMed 21151127
Validation of a cholangiographic prognostic model in primary sclerosing cholangitis
Endoscopy, 42 (9), 742-7
DOI 10.1055/s-0030-1255527, PubMed 20623444
Publications 2009
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
Carcinogenesis, 30 (7), 1147-54
DOI 10.1093/carcin/bgp118, PubMed 19443904
Genome-wide association analysis in primary sclerosing cholangitis
Gastroenterology, 138 (3), 1102-11
DOI 10.1053/j.gastro.2009.11.046, PubMed 19944697
[Liver transplantation in Norway through 25 years]
Tidsskr Nor Laegeforen, 129 (24), 2587-92
DOI 10.4045/tidsskr.09.1106, PubMed 20029553
Publications 2008
Gallbladder polyps in primary sclerosing cholangitis: not so benign
Curr Opin Gastroenterol, 24 (3), 395-9
DOI 10.1097/MOG.0b013e3282f5727a, PubMed 18408471
An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis
Am J Gastroenterol, 103 (4), 1045; author reply 1045-6
DOI 10.1111/j.1572-0241.2007.01772_5.x, PubMed 18397431
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
Hepatology, 47 (1), 90-6
DOI 10.1002/hep.21964, PubMed 18023027
Publications 2007
Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis
J Hepatol, 46 (5), 899-906
DOI 10.1016/j.jhep.2007.01.032, PubMed 17383044
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
Genes Immun, 8 (3), 275-8
DOI 10.1038/sj.gene.6364377, PubMed 17301827
Genetic epidemiology of primary sclerosing cholangitis
World J Gastroenterol, 13 (41), 5421-31
DOI 10.3748/wjg.v13.i41.5421, PubMed 17907284
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
Tissue Antigens, 69 (2), 161-9
DOI 10.1111/j.1399-0039.2006.00738.x, PubMed 17257319
Publications 2006
Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis
Clin Gastroenterol Hepatol, 4 (4), 514-20
DOI 10.1016/j.cgh.2005.10.007, PubMed 16616358
Liver transplantation in primary sclerosing cholangitis
Semin Liver Dis, 26 (1), 69-79
DOI 10.1055/s-2006-933565, PubMed 16496235
ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
Clin Transplant, 20 (2), 265-8
DOI 10.1111/j.1399-0012.2005.00470.x, PubMed 16640538
Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis
J Hepatol, 45 (4), 568-74
DOI 10.1016/j.jhep.2006.05.010, PubMed 16879890
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis
J Hepatol, 45 (5), 704-10
DOI 10.1016/j.jhep.2006.03.012, PubMed 16750586
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis
Am J Gastroenterol, 102 (1), 115-21
DOI 10.1111/j.1572-0241.2006.00928.x, PubMed 17100974
Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis
Gastroenterology, 131 (3), 781-7
DOI 10.1053/j.gastro.2006.05.057, PubMed 16952547
The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients
Tissue Antigens, 68 (1), 78-81
DOI 10.1111/j.1399-0039.2006.00604.x, PubMed 16774544
Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation
Scand J Gastroenterol, 41 (5), 592-6
DOI 10.1080/00365520500347113, PubMed 16638703
[Fulminant hepatic failure in malignant liver disease]
Tidsskr Nor Laegeforen, 126 (7), 917-8
PubMed 16554884
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
Scand J Gastroenterol, 41 (5), 586-91
DOI 10.1080/00365520500377870, PubMed 16638702
Publications 2005
Prognosis of autoimmune liver diseases
FALK SYMP, 142, 233-246
Chernopreventive effect of ursodeoxycholic acid in primary sclerosing cholangitis?
FALK SYMP, 141, 242-249
Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors
Liver Transpl, 11 (11), 1361-9
DOI 10.1002/lt.20444, PubMed 16184522
Standard treatment for primary sclerosing cholangitis and overlap autoimmune hepatitis/primary sclerosing cholangitis
FALK SYMP, 142, 203-207
Publications 2004
Liver transplantation for primary sclerosing cholangitis
J Hepatol, 40 (4), 570-7
DOI 10.1016/j.jhep.2004.01.021, PubMed 15030971
Primary sclerosing cholangitis: diagnosis and differential diagnosis
FALK SYMP, 136, 203-217
Diagnosis and treatment of cholangiocarcinoma
Curr Gastroenterol Rep, 6 (1), 52-9
DOI 10.1007/s11894-004-0026-1, PubMed 14720454
Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
J Hepatol, 40 (5), 815-22
DOI 10.1016/j.jhep.2004.01.002, PubMed 15094230
Recurrent sclerosing cholangitis or ischemic bile duct lesions--a diagnostic challenge?
Liver Transpl, 10 (8), 1073-4
DOI 10.1002/lt.20192, PubMed 15390337
Primary sclerosing cholangitis and inflammatory bowel disease: when and how do they relate to each other?
FALK SYMP, 136, 283-288
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J Hepatol, 41 (2), 209-14
DOI 10.1016/j.jhep.2004.04.024, PubMed 15288468
Publications 2003
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)3, s.320-7
BIBSYS 041707508
Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients
Scand J Gastroenterol, 38 (9), 991-5
DOI 10.1080/00365520310005172, PubMed 14531538
Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation
J Hepatol, 39 (3), 453
DOI 10.1016/s0168-8278(03)00326-x, PubMed 12927935
Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list
Liver Transpl, 9 (9), 961-9
DOI 10.1053/jlts.2003.50169, PubMed 12942458
Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries
Scand J Gastroenterol, 38 (11), 1176-83
DOI 10.1080/00365520310006009, PubMed 14686722
Hepatic and extrahepatic malignancies and primary sclerosing cholangitis
Gut, 52 (2), 165
DOI 10.1136/gut.52.2.165, PubMed 12524391
Publications 2002
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis
Gut, 51 (5), 731-5
DOI 10.1136/gut.51.5.731, PubMed 12377815
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation
Scand J Gastroenterol, 37 (10), 1205-11
DOI 10.1080/003655202760373434, PubMed 12408527
Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis
Hepatology, 35 (3), 652-7
DOI 10.1053/jhep.2002.31872, PubMed 11870380
Endoscopic treatment for primary sclerosing cholangitis?
J Hepatol, 36 (2), 278-9
DOI 10.1016/s0168-8278(01)00292-6, PubMed 11830341
Publications 2001
Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?
Transplant Proc, 33 (4), 2511-3
DOI 10.1016/s0041-1345(01)02080-2, PubMed 11406230
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis
Scand J Gastroenterol, 36 (8), 886-90
DOI 10.1080/003655201750313441, PubMed 11495087
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
J Hepatol, 34 (6), 792-8
DOI 10.1016/s0168-8278(01)00042-3, PubMed 11451160
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis
Gut, 49 (2), 288-94
DOI 10.1136/gut.49.2.288, PubMed 11454808
Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia
Clin Transplant, 15 (6), 432-6
DOI 10.1034/j.1399-0012.2001.150612.x, PubMed 11737122
Epidemiology of primary sclerosing cholangitis
Best Pract Res Clin Gastroenterol, 15 (4), 553-62
DOI 10.1053/bega.2001.0204, PubMed 11492967
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles
Hepatology, 34 (4 Pt 1), 625-30
DOI 10.1053/jhep.2001.27543, PubMed 11584356
Publications 2000
Liver transplantation in patients over 60 years of age
Transpl Int, 13 Suppl 1, S165-70
DOI 10.1007/s001470050315, PubMed 11111989
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development
J Hepatol, 32 (3), 374-80
DOI 10.1016/s0168-8278(00)80386-4, PubMed 10735605
Primary sclerosing cholangitis: challenges of a new millenium
Dig Liver Dis, 32 (9), 753-5
DOI 10.1016/s1590-8658(00)80350-3, PubMed 11215553
Publications 1999
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results
Scand J Gastroenterol, 34 (7), 714-22
DOI 10.1080/003655299750025930, PubMed 10466884
Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?
Thromb Haemost, 81 (3), 378-81
PubMed 10102464
Severe liver failure in exertional heat stroke
Scand J Gastroenterol, 34 (8), 824-7
DOI 10.1080/003655299750025778, PubMed 10499485
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations
Tissue Antigens, 53 (5), 459-69
DOI 10.1034/j.1399-0039.1999.530502.x, PubMed 10372541
[Liver transplantation--development and experiences]
Tidsskr Nor Laegeforen, 119 (22), 3310-4
PubMed 10533415
Publications 1998
Topiramate and fulminant liver failure
Lancet, 352 (9134), 1119
DOI 10.1016/s0140-6736(05)79759-2, PubMed 9798593
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia
Scand J Infect Dis, 30 (5), 520-2
DOI 10.1080/00365549850161575, PubMed 10066058
The Internet--friend or foe to scientific journals?
Scand J Gastroenterol, 33 (3), 223
DOI 10.1080/00365529850170757, PubMed 9548611
Publications 1997
Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques
Eur J Gastroenterol Hepatol, 9 (6), 575-80
DOI 10.1097/00042737-199706000-00005, PubMed 9222729
[Hepatic vein thrombosis. Diagnostic and therapeutic difficulties]
Tidsskr Nor Laegeforen, 117 (9), 1274-6
PubMed 9182354
[Treatment of cholestatic liver diseases with ursodeoxycholic acid]
Tidsskr Nor Laegeforen, 117 (23), 3370-3
PubMed 9411890
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325
How to report randomized controlled trials. The CONSORT statement. Consolidated Standards Of Reporting Trials
Scand J Gastroenterol, 32 (12), 1185-6
DOI 10.3109/00365529709028143, PubMed 9438312
Publications 1996
[Liver transplantation in Norway. Results after 10 years and 114 transplantations]
Tidsskr Nor Laegeforen, 116 (1), 19-24
PubMed 8553329
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
Hepatology, 23 (6), 1369-76
DOI 10.1002/hep.510230612, PubMed 8675153
[Is liver transplantation a therapeutic possibility of low priority in Norway?]
Tidsskr Nor Laegeforen, 116 (1), 72-6
PubMed 8553343
[Treatment of hepatitis C]
Tidsskr Nor Laegeforen, 116 (15), 1792-4
PubMed 8693463
Publications 1995
Monstrous ascites in hereditary haemorrhagic telangiectasia
Scand J Gastroenterol, 30 (1), 92-4
DOI 10.3109/00365529509093242, PubMed 7701258
Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study
Scand J Gastroenterol, 30 (8), 789-96
DOI 10.3109/00365529509096329, PubMed 7481548
Involvement of guanylate cyclase and phosphodiesterases in the functional heterogeneity of human blood platelet subpopulations
Thromb Res, 80 (6), 461-70
DOI 10.1016/0049-3848(95)00201-4, PubMed 8610274
Hepatic retention of copper and selenium in primary sclerosing cholangitis
Scand J Gastroenterol, 30 (12), 1200-3
DOI 10.3109/00365529509101631, PubMed 9053974
Publications 1994
Etiology and pathogenesis in primary sclerosing cholangitis
Scand J Gastroenterol Suppl, 204, 47-58
DOI 10.3109/00365529409103625, PubMed 7824878
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis
Scand J Gastroenterol, 29 (8), 744-52
DOI 10.3109/00365529409092504, PubMed 7973436
[Treatment of paracetamol poisoning. An indication for liver transplantation?]
Tidsskr Nor Laegeforen, 114 (10), 1199-203
PubMed 8209319
Is a 3-day waiting list appropriate for patients with acute liver failure?
Transplant Proc, 26 (3), 1786-7
PubMed 8030134
Duplex Doppler sonography and angiography in the evaluation for liver transplantation
Acta Radiol, 35 (1), 1-5
PubMed 8305264
Liver disease in anti-hepatitis C virus-positive Norwegian blood donors
Scand J Gastroenterol, 29 (1), 77-81
DOI 10.3109/00365529409090441, PubMed 8128181
Risk factors in primary sclerosing cholangitis
J Hepatol, 21 (6), 1061-6
DOI 10.1016/s0168-8278(05)80618-x, PubMed 7699228
Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients
Scand J Gastroenterol, 29 (11), 995-1000
DOI 10.3109/00365529409094876, PubMed 7871380
Publications 1993
THE VIEW CONCERNING INDUSTRIAL CHILD LABOR - AN END TO THE MISERY READING
Hist. Tidsskr., 72 (2), 209-222
Publications 1992
[Hepatitis C]
Tidsskr Nor Laegeforen, 112 (29), 3654-5
PubMed 1471122
[Spontaneous bacterial peritonitis]
Tidsskr Nor Laegeforen, 112 (2), 199-201
PubMed 1566247
[Natural products can be hazardous to health]
Tidsskr Nor Laegeforen, 112 (10), 1308-11
PubMed 1579916
Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors
Surgery, 111 (1), 48-54
PubMed 1728075
Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases
Gastroenterology, 102 (3), 1088-90
DOI 10.1016/0016-5085(92)90213-i, PubMed 1537507
Publications 1991
Increased lymphatic flow from the liver in different intra- and extrahepatic diseases demonstrated by CT
J Comput Assist Tomogr, 15 (4), 550-4
DOI 10.1097/00004728-199107000-00004, PubMed 2061465
PROPHYLAXIS OF 1ST HEMORRHAGE FROM ESOPHAGEAL-VARICES BY SCLEROTHERAPY, PROPRANOLOL OR BOTH IN CIRRHOTIC-PATIENTS - A RANDOMIZED MULTICENTER TRIAL
Hepatology, 14 (6), 1016-1024
Relationship of inflammatory bowel disease and primary sclerosing cholangitis
Semin Liver Dis, 11 (1), 31-9
DOI 10.1055/s-2008-1040420, PubMed 2047887
Psoriasis induced by interferon-alpha
Br J Dermatol, 125 (5), 463-5
DOI 10.1111/j.1365-2133.1991.tb14774.x, PubMed 1751354
Liver steatosis in hypobetalipoproteinemia. A case report
J Hepatol, 13 (1), 104-11
DOI 10.1016/0168-8278(91)90871-8, PubMed 1918873
Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report
Acta Oncol, 30 (4), 523-7
DOI 10.3109/02841869109092412, PubMed 1854510
Side effects and complications after hepatic artery embolization in the carcinoid syndrome
Scand J Gastroenterol, 26 (5), 557-62
DOI 10.3109/00365529108998580, PubMed 1871548
Effect of misoprostol and antacids on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients
Scand J Gastroenterol, 26 (4), 385-91
DOI 10.3109/00365529108996499, PubMed 1903558
Publications 1990
Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease
Scand J Gastroenterol, 25 (8), 788-92
DOI 10.3109/00365529008999216, PubMed 2402584
[Chronic non-A non-B hepatitis treated with interferon]
Tidsskr Nor Laegeforen, 110 (11), 1346-8
PubMed 2111053
[Liver transplantation in fulminant hepatic failure]
Tidsskr Nor Laegeforen, 110 (26), 3372-5
PubMed 2256061
Measles and rubella antibodies in patients with chronic liver disease
J Hepatol, 11 (3), 389
DOI 10.1016/0168-8278(90)90228-j, PubMed 2290032
Hepatic lesions in adult coeliac disease
Scand J Gastroenterol, 25 (7), 656-62
DOI 10.3109/00365529008997589, PubMed 2396080
Factors of prognostic importance in primary biliary cirrhosis
Scand J Gastroenterol, 25 (2), 119-26
DOI 10.3109/00365529009107932, PubMed 2305209
The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
Scand J Gastroenterol, 25 (11), 1169-74
DOI 10.3109/00365529008998550, PubMed 2177219
[Primary sclerosing cholangitis and inflammatory bowel disease]
Tidsskr Nor Laegeforen, 110 (10), 1212-6
PubMed 1970674
Enzyme activities in the gastric mucosa in duodenal ulcer patients
Scand J Gastroenterol, 25 (6), 594-600
DOI 10.3109/00365529009095535, PubMed 2359990
Effect of ranitidine on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients
Scand J Gastroenterol, 25 (11), 1123-8
DOI 10.3109/00365529008998544, PubMed 2274735
Publications 1989
Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization
Scand J Gastroenterol, 24 (7), 787-95
DOI 10.3109/00365528909089215, PubMed 2477894
Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report
Acta Oncol, 28 (3), 439-43
DOI 10.3109/02841868909111219, PubMed 2742781
Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway
Scand J Gastroenterol, 24 (10), 1271-5
DOI 10.3109/00365528909090798, PubMed 2602908
Measles-specific nucleotide sequences and autoimmune chronic active hepatitis
Lancet, 1 (8651), 1390-1
DOI 10.1016/s0140-6736(89)92836-5, PubMed 2567403
Association of primary sclerosing cholangitis and celiac disease: fact or fancy?
Hepatology, 10 (6), 1020-1
DOI 10.1002/hep.1840100624, PubMed 2583678
Enzyme activities in the duodenal mucosa in duodenal ulcer patients
Scand J Gastroenterol, 24 (2), 244-50
DOI 10.3109/00365528909093042, PubMed 2928738
Publications 1988
Epidemiology of ulcerative colitis in western Norway
Scand J Gastroenterol, 23 (5), 517-22
DOI 10.3109/00365528809093904, PubMed 3399823
[Etiology of chronic pancreatitis]
Tidsskr Nor Laegeforen, 108 (31), 2834-7
PubMed 3201447
Hepatobiliary complications of inflammatory bowel disease
Semin Liver Dis, 8 (3), 201-9
DOI 10.1055/s-2008-1040541, PubMed 3068805
Publications 1987
Flow cytometry of biopsy specimens from ulcerative colitis, colorectal adenomas, and carcinomas
Scand J Gastroenterol, 22 (10), 1231-7
DOI 10.3109/00365528708996469, PubMed 3433012
Enzyme activities in biopsy specimens from large-bowel mucosa in ulcerative colitis
Scand J Gastroenterol, 22 (4), 443-8
DOI 10.3109/00365528708991488, PubMed 3602924
Enzyme activities in biopsy specimens from large-bowel mucosa in colorectal adenomas and carcinomas
Scand J Gastroenterol, 22 (5), 533-8
DOI 10.3109/00365528708991893, PubMed 3629177
The immediate effect of human renal transplantation on basal and meal-stimulated levels of gastrointestinal hormones
Scand J Gastroenterol, 22 (1), 42-6
DOI 10.3109/00365528708991854, PubMed 2882597
Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease
J Hepatol, 4 (2), 229-35
DOI 10.1016/s0168-8278(87)80085-5, PubMed 3584932
Diminution of postprandial release of pancreatic polypeptide in myotonic dystrophy
Acta Neurol Belg, 87 (2), 66-9
PubMed 3577661
Flow cytometric DNA studies in human gastric cancer and polyps
Scand J Gastroenterol, 22 (10), 1270-6
DOI 10.3109/00365528708996475, PubMed 3433017
Flow cytometric DNA studies in normal human gastric mucosa, gastritis, and resected stomachs
Scand J Gastroenterol, 22 (6), 750-6
DOI 10.3109/00365528709011154, PubMed 3659836
Chronic complaints and complement aberrations after acute Yersinia enterocolitica infection
Contrib Microbiol Immunol, 9, 155-60
PubMed 3665493
Primary sclerosing cholangitis
Scand J Gastroenterol, 22 (6), 641-3
DOI 10.3109/00365528709011136, PubMed 3659825
An autoantibody profile in primary sclerosing cholangitis
J Hepatol, 5 (1), 14-8
DOI 10.1016/s0168-8278(87)80055-7, PubMed 3498749
Primary sclerosing cholangitis: a long-term follow-up study
Scand J Gastroenterol, 22 (6), 655-64
DOI 10.3109/00365528709011139, PubMed 3659828
Publications 1986
Enzyme activities in biopsy specimens from human gastric mucosa
Scand J Gastroenterol, 21 (9), 1051-7
DOI 10.3109/00365528608996419, PubMed 3810004
Longitudinal distribution of mucosal enzymes in the human large bowel
Scand J Gastroenterol, 21 (8), 919-27
DOI 10.3109/00365528608996396, PubMed 3775257
DOES LIVER-TRANSPLANTATION CORRECT THE METABOLIC DEFECT IN HEREDITARY TYROSINEMIA
Transplant. Proc., 18 (1), 67-68
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction
J Inherit Metab Dis, 9 (2), 216-24
DOI 10.1007/BF01799465, PubMed 3091928
Enzyme activities in human gastric cancer and polyps
Scand J Gastroenterol, 21 (10), 1250-6
DOI 10.3109/00365528608996451, PubMed 3809999
Enzyme activities in human gastric mucosa in gastritis and resected stomachs
Scand J Gastroenterol, 21 (10), 1257-64
DOI 10.3109/00365528608996452, PubMed 3810000
[Ultrasonic diagnosis in parenchymal liver disease]
Tidsskr Nor Laegeforen, 106 (13), 1101-3
PubMed 3523825
[Viral hepatitis. New clinical aspects]
Tidsskr Nor Laegeforen, 106 (23), 1804-6
PubMed 3764854
Treatment of bleeding oesophageal varices
Scand J Gastroenterol, 21 (8), 897-9
DOI 10.3109/00365528608996392, PubMed 3535011
Publications 1985
Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis
Scand J Gastroenterol, 20 (4), 539-42
DOI 10.3109/00365528509089693, PubMed 3875140
[Intrahepatic cholestasis. A review and a case report of benign recurrent intrahepatic cholestasis]
Tidsskr Nor Laegeforen, 105 (31), 2211-3
PubMed 4082133
The effect of gastric bypass operation on glucose tolerance in obesity
Scand J Gastroenterol Suppl, 107, 24-31
DOI 10.3109/00365528509099748, PubMed 3885381
Follow-up and prospective studies of the classification of liver disease
Scand J Gastroenterol Suppl, 107, 40-51
DOI 10.3109/00365528509099751, PubMed 3856934
[Tumor of Vater's ampulla]
Tidsskr Nor Laegeforen, 105 (32), 2296-9
PubMed 4082141
Publications 1984
[Chronic pancreatitis associated with ulcerative colitis and sclerosing cholangitis. A case report]
Tidsskr Nor Laegeforen, 104 (8), 585-7
PubMed 6719423
Dopaminergic and adrenergic influence on gastric acid and pepsin secretion stimulated by food. The role of vagal innervation
Scand J Gastroenterol Suppl, 89, 113-6
PubMed 6429838
DOPAMINERGIC AND ADRENERGIC INFLUENCE ON GASTRIC-ACID AND PEPSIN-SECRETION STIMULATED BY FOOD - THE ROLE OF VAGAL INNERVATION
Scand. J. Gastroenterol., 19 89, 113-116
[Ultrasonics and endoscopic retrograde cholangiopancreatography (ERCP). Value in suspected liver, biliary and pancreatic disease]
Tidsskr Nor Laegeforen, 104 (19-21), 1315-7
PubMed 6740630
[Gallstone--surgical or drug therapy?]
Nord Med, 99 (6-7), 167-9
PubMed 6473086
[Primary liver cancer. Diagnosis, therapy and prognosis]
Tidsskr Nor Laegeforen, 104 (3), 147-9
PubMed 6701849
Publications 1983
[Acute upper gastrointestinal hemorrhage. New aspects in the prevention and treatment]
Tidsskr Nor Laegeforen, 103 (14), 1158-60
PubMed 6603678
The release of human pancreatic polypeptide, gastrin, gastric inhibitory polypeptide, and somatostatin in celiac disease related to the histological appearance of jejunal mucosa before and 1 year after gluten withdrawal
Scand J Gastroenterol, 18 (2), 169-75
DOI 10.3109/00365528309181579, PubMed 6143393
The effect of histamine, H1 and H2 agonists, and H1 and H2 antagonists on postprandial pancreatic polypeptide release in dogs
Scand J Gastroenterol, 18 (2), 165-8
DOI 10.3109/00365528309181578, PubMed 6143392
Effects of dopamine and dopamine antagonists on postprandial release of pancreatic polypeptide in dogs and in healthy volunteers
Scand J Gastroenterol, 18 (1), 81-5
DOI 10.3109/00365528309181563, PubMed 6144173
The effect of alpha- and beta-adrenergic agonists and blockers on postprandial pancreatic polypeptide release in dogs
Scand J Gastroenterol, 18 (1), 87-90
DOI 10.3109/00365528309181564, PubMed 6144174
Pancreatic polypeptide release stimulated by food, secretin and cholecystokinin in chronic pancreatitis
Scand J Gastroenterol, 18 (3), 385-9
DOI 10.3109/00365528309181611, PubMed 6200922
[Initiation of a dental study as a pilot study in the framework of a military services study]
Osterr Z Stomatol, 80 (6), 233-6
PubMed 6583643
Acute effects of intravenous cimetidine upon gastric secretion in patients with impaired renal function
Nephron, 33 (4), 244-7
DOI 10.1159/000182961, PubMed 6405296
Effect of cimetidine on intrinsic factor secretion stimulated by different doses of pentagastrin in patients with impaired renal function
Scand J Gastroenterol, 18 (8), 1109-14
DOI 10.3109/00365528309181849, PubMed 6424229
Publications 1982
The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis
Scand J Gastroenterol, 17 (4), 523-7
DOI 10.3109/00365528209182243, PubMed 7134879
Effect of thyrotropin-releasing hormone on gastric acid secretion in man
Scand J Gastroenterol, 17 (6), 775-80
DOI 10.3109/00365528209181092, PubMed 6818683
Diagnostic value of computed tomography in pancreatic carcinoma: a comparison with other radiologic methods
Acta Radiol Diagn (Stockh), 23 (2), 131-41
DOI 10.1177/028418518202300209, PubMed 7090850
Computed tomography and angiography in pancreatic apudomas and cystadenomas
Acta Radiol Diagn (Stockh), 23 (4), 365-72
DOI 10.1177/028418518202300404, PubMed 7158400
Effect of cholinergic and adrenergic blockade on human pancreatic polypeptide secretion in healthy subjects
Scand J Gastroenterol, 17 (6), 801-9
DOI 10.3109/00365528209181097, PubMed 7156876
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease
Scand J Gastroenterol, 17 (2), 187-91
DOI 10.3109/00365528209182038, PubMed 6982501
Sclerosing cholangitis in ulcerative colitis. A follow-up study
Scand J Gastroenterol, 17 (1), 33-9
DOI 10.3109/00365528209181041, PubMed 7134835
Hepatobiliary disease in ulcerative colitis
Scand J Gastroenterol, 17 (8), 961-4
PubMed 6762645
Physical activity and the gastrointestinal tract
Scand J Soc Med Suppl, 29, 69-70
PubMed 6958057
PHYSICAL-ACTIVITY AND THE GASTROINTESTINAL-TRACT
Scand. J. Soc. Med. (29), 69-70
Effect of cholinergic, adrenergic, and dopaminergic blockade on gastrin secretion in healthy subjects
Scand J Gastroenterol, 17 (1), 29-31
DOI 10.3109/00365528209181040, PubMed 6127788
Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease
Clin Chem, 28 (5), 1177-81
PubMed 7074900
Publications 1981
Diagnostic value of computer tomography in chronic pancreatitis: a comparison with current diagnostic tests
Acta Radiol Diagn (Stockh), 22 (6), 649-55
DOI 10.1177/028418518102200605, PubMed 7347115
Cholangiographic findings in ulcerative colitis
Acta Radiol Diagn (Stockh), 22 (2), 151-7
DOI 10.1177/028418518102200208, PubMed 6269359
Partial hepatectomy in Caroli's disease
Scand J Gastroenterol, 16 (5), 581-5
DOI 10.3109/00365528109182015, PubMed 7323694
PARTIAL-HEPATECTOMY IN CAROLIS-DISEASE
Scand. J. Gastroenterol., 16 (5), 580-585
Gastrin secretion before and after gastric bypass surgery for morbid obesity
Scand J Gastroenterol, 16 (6), 721-5
DOI 10.3109/00365528109180995, PubMed 7034160
Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity
Scand J Gastroenterol, 16 (8), 1009-14
DOI 10.3109/00365528109181020, PubMed 7038840
Incidence of malignancies of the Billroth II operated stomach. A prospective follow-up
Scand J Gastroenterol Suppl, 67, 169-71
PubMed 6941399
INCIDENCE OF MALIGNANCIES OF THE BILLROTH-II OPERATED STOMACH - A PROSPECTIVE FOLLOW-UP
Scand. J. Gastroenterol., 16 67, 169-171
Publications 1980
The effect of trimipramine, cimetidine and atropine on gastric secretion
Scand J Gastroenterol Suppl, 58, 53-6
PubMed 6929093
The effect of trimipramine, cimetidine, and atropine on gastric secretion
Scand J Gastroenterol, 15 (2), 177-82
DOI 10.3109/00365528009181451, PubMed 7384741
THE EFFECT OF TRIMIPRAMINE, CIMETIDINE AND ATROPINE ON GASTRIC-SECRETION
Scand. J. Gastroenterol., 15 58, 53-56
PAPERS PRESENTED AT THE SYMPOSIUM ON PATHO-PHYSIOLOGY AND DRUG-THERAPY OF PEPTIC-ULCER - OSLO, 15-17 MARCH 1979 .1. - INTRODUCTION
Scand. J. Gastroenterol., 15 58, 5
The effect of antacids on gastrin release
Scand J Gastroenterol Suppl, 58, 25-8
PubMed 6988939
THE EFFECT OF ANTACIDS ON GASTRIN-RELEASE
Scand. J. Gastroenterol., 15 58, 25-28
Sclerosing cholangitis in ulcerative colitis
Scand J Gastroenterol, 15 (6), 689-97
DOI 10.3109/00365528009181516, PubMed 7209379
[Physical activity and the gastrointestinal tract]
Tidsskr Nor Laegeforen, 100 (12B), 763-4
PubMed 7404515
Symposium on Pathophysiology and Drug Therapy of Peptic Ulcer
In Scandinavian journal of gastroenterology, Supplement, Taylor & Francis, Basingstoke, 58, 118 s.
BIBSYS 021231567
A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
J Endocrinol Invest, 3 (3), 279-82
DOI 10.1007/BF03348276, PubMed 6159391
Publications 1979
Serum concentration of trimipramine (Surmontil) and gastric secretion of acid and pepsin following peroral administration of the drug in healthy humans
Scand J Gastroenterol, 14 (2), 237-40
DOI 10.3109/00365527909179876, PubMed 373073
Malignancy in colonoscopically removed polyps
Front Gastrointest Res, 4, 198-201
DOI 10.1159/000402302, PubMed 428893
[Peptide-producing neoplasms in the gastrointestinal tract]
Tidsskr Nor Laegeforen, 99 (9-10), 465-6
PubMed 220750
Publications 1978
The effect of TRIMIPRAMINE (Surmontil) on the stimulated gastric secretion and serum gastrin concentration in healthy students
Scand J Gastroenterol Suppl, 48, 7-49
PubMed 27861
EFFECT OF TRIMIPRAMINE (SURMONTIL) ON STIMULATED GASTRIC-SECRETION AND SERUM GASTRIN CONCENTRATION IN HEALTHY STUDENTS
Scand. J. Gastroenterol., 13 48, 7-49
Comparison of juice obtained during duodenal aspiration and cannulation of the main pancreatic duct after stimulation with exogenous secretin in man
Scand J Gastroenterol, 13 (4), 453-8
DOI 10.3109/00365527809181921, PubMed 675156
The inhibitory action of somatostatin on the stomach
Adv Exp Med Biol, 106, 235-40
DOI 10.1007/978-1-4684-7248-6_31, PubMed 717165
A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man
Clin Endocrinol (Oxf), 8 (5), 391-5
DOI 10.1111/j.1365-2265.1978.tb02173.x, PubMed 348347
Somatostatin inhibits gastric motility in response to distention
Scand J Gastroenterol, 13 (2), 145-8
DOI 10.3109/00365527809181740, PubMed 635455
Publications 1977
The effect of trimipramine (Surmontil) on gastric secretion and the serum gastrin release in healthy young students
Scand J Gastroenterol Suppl, 43, 7-17
PubMed 323962
EFFECT OF TRIMIPRAMINE (SURMONTIL) ON GASTRIC-SECRETION AND SERUM GASTRIN RELEASE IN HEALTHY YOUNG STUDENTS
Scand. J. Gastroenterol., 12 43, 7-17
Plasma gastrin and gastric secretory response to duodenal perfusion with liver extract in healthy human subjects
Scand J Gastroenterol, 12 (7), 865-8
DOI 10.3109/00365527709181731, PubMed 339324
Secretion of calcitonin and gastrin in rats with transplanted medullary thyroid carcinoma
Acta Pathol Microbiol Scand A, 85A (1), 63-72
DOI 10.1111/j.1699-0463.1977.tb03869.x, PubMed 835355
[Current diagnostic possibilities in pancreatic diseases]
Tidsskr Nor Laegeforen, 97 (6), 297-300
PubMed 847676
The effect of atropine on insulin stimulated gastric secretion and gastrin release
Mater Med Pol, 9 (2), 101-3
PubMed 895183
Mucosal changes in the gastric stump 20-25 years after partial gastrectomy
Lancet, 2 (8036), 467-9
DOI 10.1016/s0140-6736(77)91599-9, PubMed 70685
The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man
Scand J Gastroenterol, 12 (7), 833-9
DOI 10.3109/00365527709181727, PubMed 339322
Publications 1976
The intestinal phase of gastric secretion. Response to liver extract infusion into the proximal jejunum of healthy human subjects
Scand J Gastroenterol, 11 (4), 415-9
PubMed 935804
INTESTINAL PHASE OF GASTRIC-SECRETION - RESPONSE TO LIVER EXTRACT INFUSION INTO PROXIMAL JEJUNUM OF HEALTHY HUMAN SUBJECTS
Scand. J. Gastroenterol., 11 (4), 415-419
The effect of somatostatin on gastrin release and gastric secretion
Scand J Gastroenterol Suppl, 42, 41-2
PubMed 1070794
EFFECT OF SOMATOSTATIN ON GASTRIN RELEASE AND GASTRIC-SECRETION
Scand. J. Gastroenterol., 11 42, 41-42
Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients
Scand J Gastroenterol, 11 (5), 517-20
PubMed 785589
Effect of small bowel bypass on serum gastrin levels and gastric acid secretion in man
Scand J Gastroenterol, 11 (3), 329-32
PubMed 1273508
Publications 1975
Fasting serum gastrin and basal gastric acid secretion
Scand J Gastroenterol, 10 (7), 721-4
PubMed 1188305
The effect of carbachol and pentagastrin on the gastric secretion of acid pepsin, and intrinsic factor (IF) in man
Scand J Gastroenterol, 10 (1), 55-8
PubMed 235784
EFFECT OF CARBACHOL AND PENTAGASTRIN ON GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC FACTOR(IF) IN MAN
Scand. J. Gastroenterol., 10 (1), 55-58
The effect of atropine and vagotomy on the secretion of gastric intrinsic factor (IF) in man
Scand J Gastroenterol, 10 (1), 59-64
PubMed 235785
EFFECT OF ATROPINE AND VAGOTOMY ON SECRETION OF GASTRIC INTRINSIC FACTOR(IF) IN MAN
Scand. J. Gastroenterol., 10 (1), 59-64
Publications 1974
Studies on the regulation of the plasma gastrin concentration
Forfatteren, Oslo, 1b.(fl.pag.)
BIBSYS 010725377
Effect of atropine on plasma concentration of gastrin in fasting subjects
Scand J Gastroenterol, 9 (2), 123-5
PubMed 4818390
Serum gastrin and gastric acid secretion before and after proximal gastric vagotomy
Scand J Gastroenterol, 9 (2), 115-8
PubMed 4818388
Effect of gastric distention on motility and plasma gastrin concentration before and after secretin administration
Scand J Gastroenterol, 9 (2), 119-22
PubMed 4818389
Effect of atropine on insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF)
Scand J Gastroenterol, 9 (7), 665-9
PubMed 4610710
Intragastric pressure-volume relationship and gastrin release after distention of separate parts of the stomach
Scand J Gastroenterol, 9 (8), 781-5
PubMed 4432051
The effect of gastric distention on gastric motility and serum gastrin in acutely vagotomized pigs
Scand J Gastroenterol, 9 (2), 127-31
PubMed 4818391
EFFECT OF GASTRIC DISTENTION ON GASTRIC MOTILITY AND SERUM GASTRIN IN ACUTELY VAGOTOMIZED PIGS
Scand. J. Gastroenterol., 9 (2), 127-131
The effect of calcium and pentagastrin on the gastric secretion of acid, pepsin, and intrinsic factor (IF) in man
Scand J Gastroenterol, 9 (7), 697-701
PubMed 4610713
EFFECT OF CALCIUM AND PENTAGASTRIN ON GASTRIC-SECRETION OF ACID, PEPSIN, AND INTRINSIC-FACTOR (IF) IN MAN
Scand. J. Gastroenterol., 9 (7), 697-701
Publications 1973
The effect of secretin on plasma concentration of gastrin in fasting patients with carcinoma of the stomach
Scand J Gastroenterol, 8 (6), 479-82
PubMed 4772201
EFFECT OF SECRETIN ON PLASMA CONCENTRATION OF GASTRIN IN FASTING PATIENTS WITH CARCINOMA OF STOMACH
Scand. J. Gastroenterol., 8 (6), 479-482
The effect of secretin on plasma gastrin in the Zollinger-Ellison syndrome
Scand J Gastroenterol, 8 (2), 145-50
PubMed 4697075
EFFECT OF SECRETIN ON PLASMA GASTRIN IN ZOLLINGER-ELLISON SYNDROME
Scand. J. Gastroenterol., 8 (2), 145-150
The metabolic clearance rate and half-life of synthetic human gastrin in dogs
Scand J Gastroenterol, 8 (3), 203-7
PubMed 4724919
METABOLIC CLEARANCE RATE AND HALF-LIFE OF SYNTHETIC HUMAN GASTRIN IN DOGS
Scand. J. Gastroenterol., 8 (3), 203-207
Metabolic clearance and disappearance rates of synthetic human gastrin in man
Scand J Gastroenterol, 8 (8), 731-4
PubMed 4771113
Publications 1972
Radioimmunoassay of gastrin with activated charcoal
Scand J Gastroenterol, 7 (8), 683-7
DOI 10.3109/00365527209180977, PubMed 4640642
Publications 1971
[Treatment of the microbial lower-leg eczema with special reference to diabetes mellitus]
Z Haut Geschlechtskr, 46 (19), 637-9
PubMed 5137246
Publications 1970
Vitamin B 12 in the serum and the cerebrospinal fluid
Acta Neurol Scand, 46 (2), 243-8
DOI 10.1111/j.1600-0404.1970.tb05620.x, PubMed 5431458
Publications 1969
[Supplemental effect of beta-aescin by vasodilator agents]
Wien Med Wochenschr, 119 (42), 721-2
PubMed 4391303
[Significance of local antibiotic therapy in the treatment of indolent ulcer. (Clinical results)]
Z Haut Geschlechtskr, 44 (18), 775-6
PubMed 5382946
Publications 1968
[Dermatologic experiences with a new ointment foundation with the saturated fatty acid glyceride base]
Wien Med Wochenschr, 118 (3), 47-52
PubMed 4233268
Publications 1966
[Therapeutic results with a new ointment foundation on basis of synthetic glycerides of saturated fatty acids]
Dermatol Wochenschr, 152 (26), 660-71
PubMed 5963477